Similar articles

• c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells.

  Touyz RM, Yao G, Schiffrin EL. Touyz RM, et al. Arterioscler Thromb Vasc Biol. 2003 Jun 1;23(6):981-7. doi: 10.1161/01.ATV.0000069236.27911.68. Epub 2003 Mar 27. Arterioscler Thromb Vasc Biol. 2003. PMID: 12663375
• Gene transfer of NAD(P)H oxidase inhibitor to the vascular adventitia attenuates medial smooth muscle hypertrophy.

  Liu J, Ormsby A, Oja-Tebbe N, Pagano PJ. Liu J, et al. Circ Res. 2004 Sep 17;95(6):587-94. doi: 10.1161/01.RES.0000142317.88591.e6. Epub 2004 Aug 12. Circ Res. 2004. PMID: 15308582
• Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells.

  Bouallegue A, Vardatsikos G, Srivastava AK. Bouallegue A, et al. Can J Physiol Pharmacol. 2009 Dec;87(12):1009-18. doi: 10.1139/Y09-056. Can J Physiol Pharmacol. 2009. PMID: 20029537
• NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling.

  Hanna IR, Taniyama Y, Szöcs K, Rocic P, Griendling KK. Hanna IR, et al. Antioxid Redox Signal. 2002 Dec;4(6):899-914. doi: 10.1089/152308602762197443. Antioxid Redox Signal. 2002. PMID: 12573139 Review.
• The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases.

  Cai H, Griendling KK, Harrison DG. Cai H, et al. Trends Pharmacol Sci. 2003 Sep;24(9):471-8. doi: 10.1016/S0165-6147(03)00233-5. Trends Pharmacol Sci. 2003. PMID: 12967772 Review.